Credo Technology is projected to grow revenue by over 85% in fiscal 2027, with a price target of $258.39 indicating a 21.17% upside from its current price. Despite strong revenue growth and a bullish outlook on its optics business, Credo trades at a lower valuation than peers Marvell and Astera Labs. Risks include high customer concentration and margin pressures from acquisition costs. The company’s growth in AI-related optical products could push its stock price even higher, with estimates reaching $335 by 2030 if execution continues well.
Credo Technology's growth prospects highlight its current market position compared to peers. On Pluang as of Oct 13, 2026 20:12 WIB, Credo trades at USD 193.43, down 3.69% for the day, with a market cap of $37.75B. This is notably below Marvell's USD 256.91 and Astera Labs' USD 313.20 prices, which also saw declines of around 3.37%. Credo's typical hold time on Pluang is 23 days, reflecting active investor interest amid its evolving valuation landscape.
